7.93
Schlusskurs vom Vortag:
$7.87
Offen:
$7.86
24-Stunden-Volumen:
1.14M
Relative Volume:
0.81
Marktkapitalisierung:
$1.23B
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-7.1441
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+2.85%
1M Leistung:
+20.70%
6M Leistung:
-31.99%
1J Leistung:
+28.42%
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
WVE
Wave Life Sciences Ltd
|
7.93 | 1.20B | 53.61M | -142.52M | -141.83M | -1.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-16 | Eingeleitet | Citigroup | Buy |
2025-06-11 | Fortgesetzt | Raymond James | Outperform |
2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-08 | Eingeleitet | Wedbush | Outperform |
2025-02-25 | Eingeleitet | Jefferies | Buy |
2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
2024-09-09 | Eingeleitet | JP Morgan | Overweight |
2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
2023-07-05 | Eingeleitet | Raymond James | Outperform |
2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2019-11-01 | Eingeleitet | Guggenheim | Buy |
2019-07-15 | Eingeleitet | Cowen | Market Perform |
2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
2018-08-07 | Eingeleitet | Stifel | Buy |
2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
2018-03-19 | Bestätigt | Mizuho | Buy |
2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
2015-12-07 | Eingeleitet | Jefferies | Buy |
2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
Why Wave Life Sciences Ltd. stock attracts strong analyst attentionFree Join Group - Newser
What analysts say about Wave Life Sciences Ltd. stockRemarkably fast returns - jammulinksnews.com
What drives Wave Life Sciences Ltd. stock priceFree Investment Portfolio Suggestions - jammulinksnews.com
Is Wave Life Sciences Ltd. a good long term investmentSpectacular growth rates - jammulinksnews.com
Wave Life Sciences Ltd. Stock Analysis and ForecastAccelerated financial growth - Autocar Professional
(WVE) Investment Analysis - news.stocktradersdaily.com
WAVE Life Sciences (NASDAQ:WVE) Research Coverage Started at Citigroup - Defense World
Will WAVE's Q1 2025 forecast meet expectations? - AInvest
When is the best time to buy Wave Life Sciences Ltd. stockReturn Maximized Portfolio Strategy - Newser
WAVE Life Sciences Receives Buy Rating and USD 16 Price Target from Citigroup - AInvest
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions - MSN
Wave Life Sciences’ SWOT analysis: RNA editing stock poised for breakthrough - Investing.com
Jessica Chen - White & Case LLP
Breaking Down WAVE Life Sciences: 4 Analysts Share Their Views - Benzinga
Citi initiates coverage on WAVE Life Sciences stock with Buy rating - Investing.com Australia
Citi initiates coverage on WAVE Life Sciences stock with Buy rating By Investing.com - Investing.com South Africa
What makes Wave Life Sciences Ltd. stock price move sharplyFree Stock Index Interpretation - Newser
13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey
Leerink Partners Reiterates a Buy Rating on Wave Life Sciences (WVE), Keeps the PT at $24 - Yahoo Finance
Wave Life Sciences stock reiterated Overweight by Cantor Fitzgerald - Investing.com South Africa
How the (WVE) price action is used to our Advantage - news.stocktradersdaily.com
Huntington's Disease Pipeline 2025: MOA, ROA, And Clinical Trial Insights Explored By Delveinsight Spark Therapeutics, Chong Kun Dang Pharma, Neuvivo, Uniqure Biopharma, Wave Life Sciences, Novartis - Menafn.com
Wave Life Sciences: Upgrading Rating To Buy After Turbulent 10 Months (NASDAQ:WVE) - Seeking Alpha
We Think Wave Life Sciences (NASDAQ:WVE) Needs To Drive Business Growth Carefully - simplywall.st
Wave Life Sciences: Speculative, But Promising (NASDAQ:WVE) - Seeking Alpha
H.C. Wainwright Reaffirms Buy Rating on Wave Life Sciences After ADA Data Release - Yahoo Finance
Wave Life Sciences’ SWOT analysis: RNA editing stock faces fierce competition - Investing.com
WVE: Wedbush Reiterates Outperform Rating on WAVE Life Sciences | WVE Stock News - GuruFocus
Wave Life sciences stock rating reiterated by Cantor Fitzgerald - Investing.com India
Wave Life Sciences Announces Oral Presentation of Preclinical Data Supporting WVE-007's Mechanism (INHBE) to Reduce Fat, Preserve Muscle, and Induce Healthy Weight Loss at ADA's Annual Scientific Sessions - The Manila Times
Wave Life Sciences reports promising obesity treatment data By Investing.com - Investing.com Nigeria
Wave Life Sciences’s SWOT analysis: RNA editing pioneer faces fierce competition - Investing.com Canada
Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life S - GuruFocus
Insider Sell: Gregory Verdine Sells 30,000 Shares of WAVE Life Sciences Ltd (WVE) - GuruFocus
Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Raymond James - Defense World
WVE Stock Update: Raymond James Rates WAVE Life Sciences 'Outper - GuruFocus
Wave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of “Buy” from Analysts - Defense World
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders - GlobeNewswire Inc.
Equities Analysts Offer Predictions for WVE FY2026 Earnings - Defense World
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):